Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
HRSA Revises RWHAP Policy Notice on Eligibility Determinations
In October 2021, HRSA's HIV/AIDS Bureau revised its client eligibility and recertification policy for the Ryan White HIV/AIDS Program.
News Article updated on 11/02/2021 -
HRSA Releases New Fact Sheets on RWHAP Clients
Ten fact sheets on client populations getting care from the Ryan White HIV/AIDS Program (RWHAP) a
News Article updated on 06/30/2021 -
Merging Prevention and Care Planning Groups
HIV planning groups are responsible for overseeing the planning and implementation of HIV prevention and care activities within communities. Historically, prevention and care programs have operated separate planning groups. RWHAP Part A and Part B recipients and CDC-funded prevention jurisdictions have conducted parallel planning activities, oftentimes with little collaboration or coordination. As a way to reduce duplicative planning activities and streamline the work of planning groups, a number of jurisdictions have integrated their HIV planning groups.
Resource updated 09/14/2023
-
Use of Social Media and Mobile Technology as Essential Tools for EHE
Strategies to engage hard-to-reach youth and young adults through use of social media and related technologies.Resource updated 03/15/2023
-
Online Course on Integrated Planning
-
Lights, Camera, Action: Introducing an Integrated HIV Prevention and Care Planning Online Course
Introduction to the newly developed online course, An Introduction to Integrated HIV Prevention and Care Planning.Resource updated 02/28/2022
-
An Introduction to HIV Prevention and Care Planning
This self-paced course from the Integrated HIV/AIDS Planning TA Center serves as an introduction to the fundamentals of integrated planning, and is designed for anyone who is new to integrated HIV prevention and care planning or anyone who would like a refresher on the basics.
By the end of this course, you will be able to:
Resource updated 07/28/2021
-
HIV Planning Body Assessment Guide: A Resource for Integrated HIV Planning Bodies
Guide to help integrated HIV planning bodies review and evaluate the effectiveness of their structure, policies and procedures, membership, and stakeholder and consumer engagement.Resource updated 09/14/2023
-
Ending the HIV Epidemic through Innovations in Rapid ART
Review of innovative Rapid ART strategies in diverse settings.Resource updated 03/15/2023
-
Fostering Equity in HIV Planning
In this webinar, panelists discussed the ways in which power imbalances can manifest in HIV planning bodies; how their planning bodies have sought to promote equity; and strategies that can be implemented to foster equity and mitigate power imbalances based on race, education, age, and socioeconomic status.
Resource updated 11/22/2021
-
Fillable CY 2022 – 2026 CDC DHP and HRSA HAB Integrated Prevention and Care Plan Guidance Checklist
Checklist required in the submission of the Integrated Plans for 2022-2026.Resource updated 09/19/2023
-
Crosswalk of the Integrated HIV Prevention and Care Plan Guidance (CY 2016-2021 and CY 2022-2026) and the Ending the HIV Epidemic in the U.S. Program Guidance
Crosswalk of the required components of the 2022-2026 Integrated HIV Prevention and Care Plan with the 2016-2021 Integrated HIV Prevention and Care Plans and the EHE Planning Program Guidance.Resource updated 09/19/2023
-
Gearing Up for Integrated Planning: Approach, Timeline, and Community Engagement
Overview of key steps to undertaking the planning cycle, the sequence of events associated with Integrated Planning, and discussion of the importance of meaningful community engagement.Resource updated 07/07/2022
-
HIV 101: Fundamentals of HIV Pathogenesis, Antiretroviral Therapy Initiation, & Primary Care for PWH
Session for clinicians new to the field of HIV or those looking for a review on the core principles of HIV management, including pathogenesis of HIV infection, mechanism of action of antiretroviral drugs, initiating antiretroviral therapy, and primary care for people with HIV.Resource (Conference Presentation) updated 09/14/2023
-
Integrated HIV Prevention and Care Plan: Planning Requirements
Outline of the planning requirements for RWHAP Parts A and B recipients and all DHAP-funded state and local health departments as described in the Integrated HIV Prevention and Care Plan Guidance, Including the SCSN, CY 2022-2026.Resource updated 08/03/2023
-
New Investigational ART Drugs and Strategies
Review of investigational drugs in phase III trials (as of 2021: Islatravir, Lenacapravir, GSK 3640254/aka GSK “254) and how these investigational agents might be used in treatment in the future. Also, review of long-acting injectables.Resource (Conference Presentation) updated 09/14/2023
-
Managing Polypharmacy and Drug-Drug Interactions
Review of common mechanisms for drug interactions with contemporary ART; therapeutic classes of drugs with high interaction potential with ART; distinctions between oral vs intramuscular cabotegravir/rilpivirin interactions; and comparison of the clinical pharmacology and drug interaction potential of tenofovir alafenamide vs tenofovir disoproxilfumarate.Resource (Conference Presentation) updated 09/14/2023
-
Cases From the Clinic(ians): Antiretroviral Therapy Cases and Panel Discussion
Insights for clinicians on selecting antiretroviral therapy and/or managing patients who: are starting initial therapy; are Elite Controllers; have InSTI-associated weight gain; have persistent low-level viremia; have a discordant CD4+ count response to ART; have ‘Blips’; and/or are aging.Resource (Conference Presentation) updated 04/08/2024
-
Addressing HIV Practitioner and Staff Burnout in the COVID-19 Era
Discussion of recognizing the signs of burnout among clinicians and strategies for self-care.Resource (Conference Presentation) updated 09/14/2023